Ann Surg21 Apr 2025
An advanced AI tool has been developed to predict intraoperative liver resection complexity (LRC) using preoperative CT scans. By generating 3D models of anatomy, including tumors and vascular structures, the tool outperforms traditional predictions made by surgeons. With an accuracy of 79.4% and an AUC…
BMC Surg19 Apr 2025
A randomized controlled trial found that splenic artery ligation significantly decreases the incidence of grades b and c posthepatectomy liver failure in patients with elevated portal venous pressure. Among 36 participants with high pressure, those receiving the intervention had a failure rate of 16.67% compared…
Ann Surg17 Apr 2025
The PANAMA score effectively stratifies pancreatic cancer patients post-resection into low-, intermediate-, and high-risk categories, correlating with median overall survival rates of 48.5, 27.6, and 22.3 months, respectively. Adjuvant therapy demonstrated no survival benefit in low-risk patients, while significant improvements were seen in both intermediate…
HPB & Spleen17 Apr 2025
The integration of transarterial chemoembolization (TACE) with tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) notably improves the objective response rate (RR = 1.81) and disease control rate (RR = 1.32) compared to TKIs and ICIs alone. Additionally, overall survival and progression-free survival are…
Ann Surg16 Apr 2025
In a cohort study of 251 patients with pancreatic ductal adenocarcinoma, neoadjuvant therapy followed by surgical resection significantly improved overall survival (39.87 months vs. 18.86 months) and recurrence-free survival (25.67 months vs. 12.83 months) compared to upfront surgery. Elevated carcinoembryonic antigen (CEA) levels were linked…
Am J Surg Pathol16 Apr 2025
Carboxypeptidase z (cpz) demonstrates significant diagnostic potential for differentiating hepatocellular carcinoma (HCC) from intrahepatic cholangiocarcinoma (ICC). The study found cpz expressed in 90.8% of HCC cases, compared to 27.7% in ICC. Diagnostic accuracy was enhanced when cpz was combined with arginase-1 and hepatocyte paraffin antigen-1.…
Ann Surg Oncol15 Apr 2025
A novel risk-stratification model for statistical cure after hepatectomy in hepatitis B virus-associated hepatocellular carcinoma (HBV-HCC) reveals an overall cure probability of 21.2%. The study identified eight independent risk factors, including high viral load and macrovascular invasion, that significantly influence outcomes. Low-risk patients achieved a…
HPB & Spleen15 Apr 2025
An analysis of the National Health Interview Survey highlights significant financial toxicity among U.S. patients with hepatopancreatobiliary (HPB) cancers. Of 5.6 million adults, 10.1% delayed medical care due to cost, while 8.4% could not afford necessary treatment. Uninsured patients faced markedly higher odds of financial…
BMC Surg14 Apr 2025
A study assessed the learning curve of robotic pancreatoduodenectomy among a first-generation surgeon. It identified three phases: competency, proficiency, and mastery, with significant reductions in operative time and complication rates as experience increased. At 90 days, severe morbidity was 24% and mortality was 5.4%. Mastery…
BMC Surg14 Apr 2025
A retrospective analysis of 164 liver resections for primary intrahepatic lithiasis demonstrated that minimally invasive techniques, which increased to 60% of surgeries, significantly reduced morbidity and hospital stays compared to traditional open surgery. Key complications included a 16% rate of bile fistula and 30% of…